|
2021-11-12 |
2021-11-10 |
S
Venta
|
Executive Chairman
Consejero no ejecutivo
|
9 454
-33.6%
179,40
2.336.387 US$
|
9 454
-33.6%
|
179,40
|
2.336.387 US$
|
|
|
2021-11-12 |
2021-11-10 |
S
Venta
|
President and CEO
Consejero ejecutivo
|
70 135
-35.8%
69,97
1.844.168 US$
|
70 135
-35.8%
|
69,97
|
1.844.168 US$
|
|
|
2021-10-07 |
2021-10-05 |
S
Venta
|
GC & Chief Compliance Officer
Oficial
|
4 574
-47.9%
203,10
3.406.731 US$
|
4 574
-47.9%
|
203,10
|
3.406.731 US$
|
|
|
2021-08-12 |
2021-08-12 |
B
Compra
|
Chief Financial Officer
Oficial
|
1 449
+3.0%
6,89
9.976 US$
|
1 449
+3.0%
|
6,89
|
9.976 US$
|
|
|
2021-04-08 |
2021-04-06 |
S
Venta
|
VP, Controller and Interim CFO
Oficial
|
1 508
-2.3%
7,13
10.751 US$
|
1 508
-2.3%
|
7,13
|
10.751 US$
|
|
|
2021-03-25 |
2021-03-12 |
S
Venta
|
VP, Controller and Interim CFO
Oficial
|
1 582
-2.4%
7,49
11.849 US$
|
1 582
-2.4%
|
7,49
|
11.849 US$
|
|
|
2021-02-03 |
2021-02-02 |
S
Venta
|
Chief Financial Officer
Oficial
|
4 123
-3.0%
4,91
20.256 US$
|
4 123
-3.0%
|
4,91
|
20.256 US$
|
|
|
2021-01-22 |
2021-01-20 |
S
Venta
|
GC & Chief Compliance Officer
Oficial
|
4 399
-5.9%
4,49
19.752 US$
|
4 399
-5.9%
|
4,49
|
19.752 US$
|
|
|
2021-01-20 |
2021-01-13 |
S
Venta
|
Consejero no ejecutivo
|
1 973
-1.4%
4,71
9.301 US$
|
1 973
-1.4%
|
4,71
|
9.301 US$
|
|
|
2020-02-20 |
2020-02-20 |
Por favor
Venta prevista
|
Chairman of the Board and CEO
Consejero ejecutivo
|
63 557
-23.2%
5,91
375.368 US$
|
63 557
-23.2%
|
5,91
|
375.368 US$
|
|
|
2020-02-20 |
2020-02-19 |
Por favor
Venta prevista
|
Chairman of the Board and CEO
Consejero ejecutivo
|
53 513
-16.4%
5,93
317.113 US$
|
53 513
-16.4%
|
5,93
|
317.113 US$
|
|
|
2020-02-20 |
2020-02-18 |
Por favor
Venta prevista
|
Chairman of the Board and CEO
Consejero ejecutivo
|
16 506
-4.8%
6,00
98.960 US$
|
16 506
-4.8%
|
6,00
|
98.960 US$
|
|
|
2019-06-11 |
2019-06-07 |
B
Compra
|
|
20 869
+11.4%
5,75
119.997 US$
|
20 869
+11.4%
|
5,75
|
119.997 US$
|
|
|
2019-06-11 |
2019-06-07 |
B
Compra
|
Chief Financial Officer
|
17 391
+22.4%
5,75
99.998 US$
|
17 391
+22.4%
|
5,75
|
99.998 US$
|
|
|
2019-06-11 |
2019-06-07 |
B
Compra
|
|
8 696
+19.3%
5,75
50.002 US$
|
8 696
+19.3%
|
5,75
|
50.002 US$
|
|
|
2018-11-08 |
2018-11-06 |
Por favor
Venta prevista
|
Haines Timothy
Consejero no ejecutivo
|
81 137
-3.3%
21,60
1.752.559 US$
|
81 137
-3.3%
|
21,60
|
1.752.559 US$
|
|
|
2018-11-08 |
2018-11-06 |
Por favor
Venta prevista
|
Haines Timothy
Consejero no ejecutivo
|
8 514
-0.3%
21,13
179.901 US$
|
8 514
-0.3%
|
21,13
|
179.901 US$
|
|
|
2018-09-05 |
2018-08-31 |
S
Venta
|
Nugent Jeffrey M
Chairman of the Board and CEO
Consejero ejecutivo
|
1 852
-0.6%
24,90
46.115 US$
|
1 852
-0.6%
|
24,90
|
46.115 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
Haines Timothy
Consejero no ejecutivo
|
281 482
+12.8%
13,50
3.800.007 US$
|
281 482
+12.8%
|
13,50
|
3.800.007 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
Abingworth LLP
|
281 482
+12.8%
13,50
3.800.007 US$
|
281 482
+12.8%
|
13,50
|
3.800.007 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
SCHAISON PHILIPPE
Consejero no ejecutivo
|
7 407
+24.4%
13,50
99.994 US$
|
7 407
+24.4%
|
13,50
|
99.994 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
Williams Patrick F.
Chief Financial Officer & SVP
Oficial
|
7 408
+14.8%
13,50
100.008 US$
|
7 408
+14.8%
|
13,50
|
100.008 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
Nugent Jeffrey M
Chairman of the Board and CEO
Consejero ejecutivo
|
1 852
+0.6%
13,50
25.002 US$
|
1 852
+0.6%
|
13,50
|
25.002 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
Sullivan Keith J
Consejero no ejecutivo
|
7 407
+6.5%
13,50
99.994 US$
|
7 407
+6.5%
|
13,50
|
99.994 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
GREER R SCOTT
Consejero no ejecutivo
|
11 111
+26.7%
13,50
149.998 US$
|
11 111
+26.7%
|
13,50
|
149.998 US$
|
|
|
2018-05-09 |
2018-05-07 |
B
Compra
|
OBOYLE KEVIN C
Consejero no ejecutivo
|
7 407
+23.5%
13,50
99.994 US$
|
7 407
+23.5%
|
13,50
|
99.994 US$
|
|
|
2015-10-13 |
2015-10-12 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
2 785
-14.0%
5,98
16.654 US$
|
2 785
-14.0%
|
5,98
|
16.654 US$
|
|
|
2015-10-13 |
2015-10-12 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
285 106
-13.9%
5,98
1.704.934 US$
|
285 106
-13.9%
|
5,98
|
1.704.934 US$
|
|
|
2015-10-09 |
2015-10-09 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
2 041
-9.3%
7,03
14.348 US$
|
2 041
-9.3%
|
7,03
|
14.348 US$
|
|
|
2015-10-09 |
2015-10-09 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
210 668
-9.3%
7,03
1.480.996 US$
|
210 668
-9.3%
|
7,03
|
1.480.996 US$
|
|
|
2015-10-09 |
2015-10-08 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
3 837
-14.9%
7,24
27.780 US$
|
3 837
-14.9%
|
7,24
|
27.780 US$
|
|
|
2015-10-09 |
2015-10-08 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
396 163
-14.9%
7,24
2.868.220 US$
|
396 163
-14.9%
|
7,24
|
2.868.220 US$
|
|
|
2015-10-09 |
2015-10-07 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
454
-1.7%
7,36
3.341 US$
|
454
-1.7%
|
7,36
|
3.341 US$
|
|
|
2015-10-09 |
2015-10-07 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
53 446
-2.0%
7,36
393.363 US$
|
53 446
-2.0%
|
7,36
|
393.363 US$
|
|
|
2015-10-06 |
2015-10-06 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
59
-0.2%
7,80
460 US$
|
59
-0.2%
|
7,80
|
460 US$
|
|
|
2015-10-06 |
2015-10-06 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
6 941
-0.3%
7,80
54.140 US$
|
6 941
-0.3%
|
7,80
|
54.140 US$
|
|
|
2015-10-06 |
2015-10-05 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
1 163
-4.2%
8,19
9.525 US$
|
1 163
-4.2%
|
8,19
|
9.525 US$
|
|
|
2015-10-06 |
2015-10-05 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
136 937
-4.8%
8,19
1.121.514 US$
|
136 937
-4.8%
|
8,19
|
1.121.514 US$
|
|
|
2015-10-06 |
2015-10-02 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
403
-1.4%
10,34
4.167 US$
|
403
-1.4%
|
10,34
|
4.167 US$
|
|
|
2015-10-06 |
2015-10-02 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
47 497
-1.6%
10,34
491.119 US$
|
47 497
-1.6%
|
10,34
|
491.119 US$
|
|
|
2015-10-01 |
2015-10-01 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
400
-1.4%
10,34
4.136 US$
|
400
-1.4%
|
10,34
|
4.136 US$
|
|
|
2015-10-01 |
2015-10-01 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
47 100
-1.6%
10,34
487.014 US$
|
47 100
-1.6%
|
10,34
|
487.014 US$
|
|
|
2015-10-01 |
2015-09-30 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
369
-1.3%
10,17
3.753 US$
|
369
-1.3%
|
10,17
|
3.753 US$
|
|
|
2015-10-01 |
2015-09-30 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
43 471
-1.5%
10,17
442.100 US$
|
43 471
-1.5%
|
10,17
|
442.100 US$
|
|
|
2015-10-01 |
2015-09-29 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
89
-0.3%
10,08
897 US$
|
89
-0.3%
|
10,08
|
897 US$
|
|
|
2015-10-01 |
2015-09-29 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
10 469
-0.3%
10,08
105.528 US$
|
10 469
-0.3%
|
10,08
|
105.528 US$
|
|
|
2015-09-28 |
2015-09-28 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
89
-0.3%
10,30
917 US$
|
89
-0.3%
|
10,30
|
917 US$
|
|
|
2015-09-28 |
2015-09-28 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
10 513
-0.3%
10,30
108.284 US$
|
10 513
-0.3%
|
10,30
|
108.284 US$
|
|
|
2015-09-28 |
2015-09-25 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
311
-1.1%
11,07
3.443 US$
|
311
-1.1%
|
11,07
|
3.443 US$
|
|
|
2015-09-28 |
2015-09-25 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
66 489
-2.2%
11,07
736.033 US$
|
66 489
-2.2%
|
11,07
|
736.033 US$
|
|
|
2015-09-28 |
2015-09-25 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
800
-2.7%
10,07
8.056 US$
|
800
-2.7%
|
10,07
|
8.056 US$
|
|
|
2015-09-28 |
2015-09-25 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
64 400
-2.0%
10,07
648.508 US$
|
64 400
-2.0%
|
10,07
|
648.508 US$
|
|
|
2015-09-28 |
2015-09-24 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
8 152
-0.3%
11,00
89.672 US$
|
8 152
-0.3%
|
11,00
|
89.672 US$
|
|
|
2015-09-28 |
2015-09-24 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
148
-0.5%
11,00
1.628 US$
|
148
-0.5%
|
11,00
|
1.628 US$
|
|
|
2015-09-28 |
2015-09-24 |
S
Venta
|
ORBIMED ADVISORS LLC
Gran accionista
|
6
-0.0%
9,78
59 US$
|
6
-0.0%
|
9,78
|
59 US$
|
|
|
2014-11-03 |
2014-10-29 |
B
Compra
|
Haines Timothy
Consejero no ejecutivo
Gran accionista
|
495 000
+29.0%
15,00
7.425.000 US$
|
495 000
+29.0%
|
15,00
|
7.425.000 US$
|
|
|
2014-10-31 |
2014-10-29 |
B
Compra
|
Abingworth LLP
Gran accionista
|
495 000
+29.0%
15,00
7.425.000 US$
|
495 000
+29.0%
|
15,00
|
7.425.000 US$
|
|